These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25622185)

  • 1. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
    Curtis C; Gamez JE; Singh U; Sadowsky CH; Villena T; Sabbagh MN; Beach TG; Duara R; Fleisher AS; Frey KA; Walker Z; Hunjan A; Holmes C; Escovar YM; Vera CX; Agronin ME; Ross J; Bozoki A; Akinola M; Shi J; Vandenberghe R; Ikonomovic MD; Sherwin PF; Grachev ID; Farrar G; Smith AP; Buckley CJ; McLain R; Salloway S
    JAMA Neurol; 2015 Mar; 72(3):287-94. PubMed ID: 25622185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.
    Wolk DA; Grachev ID; Buckley C; Kazi H; Grady MS; Trojanowski JQ; Hamilton RH; Sherwin P; McLain R; Arnold SE
    Arch Neurol; 2011 Nov; 68(11):1398-403. PubMed ID: 21747004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
    Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
    Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of
    Reinartz M; Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Thal DR; Van Laere K; Dupont P; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3772-3786. PubMed ID: 35522322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
    Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID
    Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The translational journey of brain β-amyloid imaging: from positron emission tomography to autopsy to clinic.
    Rabinovici GD
    JAMA Neurol; 2015 Mar; 72(3):265-6. PubMed ID: 25621934
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
    Wolk DA; Sadowsky C; Safirstein B; Rinne JO; Duara R; Perry R; Agronin M; Gamez J; Shi J; Ivanoiu A; Minthon L; Walker Z; Hasselbalch S; Holmes C; Sabbagh M; Albert M; Fleisher A; Loughlin P; Triau E; Frey K; Høgh P; Bozoki A; Bullock R; Salmon E; Farrar G; Buckley CJ; Zanette M; Sherwin PF; Cherubini A; Inglis F
    JAMA Neurol; 2018 Sep; 75(9):1114-1123. PubMed ID: 29799984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
    de Lartigue J
    Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.
    Beach TG; Schneider JA; Sue LI; Serrano G; Dugger BN; Monsell SE; Kukull W
    J Neuropathol Exp Neurol; 2014 Oct; 73(10):948-53. PubMed ID: 25192053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent false positive [
    Ikonomovic MD; Fantoni ER; Farrar G; Salloway S
    Alzheimers Res Ther; 2018 Jun; 10(1):60. PubMed ID: 29935545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients.
    Wong DF; Moghekar AR; Rigamonti D; Brašić JR; Rousset O; Willis W; Buckley C; Smith A; Gok B; Sherwin P; Grachev ID
    Mol Imaging Biol; 2013 Apr; 15(2):230-7. PubMed ID: 22878921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic impact of [
    Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
    Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
    Beach TG; Thal DR; Zanette M; Smith A; Buckley C
    J Alzheimers Dis; 2016 Mar; 52(3):863-73. PubMed ID: 27031469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus.
    Rinne JO; Frantzen J; Leinonen V; Lonnrot K; Laakso A; Virtanen KA; Solin O; Kotkansalo A; Koivisto A; Sajanti J; Karppinen A; Lehto H; Rummukainen J; Buckley C; Smith A; Jones PA; Sherwin P; Farrar G; McLain R; Kailajarvi M; Grachev ID
    Neurodegener Dis; 2014; 13(4):237-45. PubMed ID: 24296542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of amyloid distribution by [
    Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
    Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making.
    Zannas AS; Doraiswamy PM; Shpanskaya KS; Murphy KR; Petrella JR; Burke JR; Wong TZ
    Neurocase; 2014 Aug; 20(4):466-73. PubMed ID: 23672654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
    Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.